Publications by authors named "V Green"

Objective: In the United States, on average, every 15 s, someone visits a hospital emergency department (ED) for a dental condition. This commentary summarizes the recommendations from a 2024 clinical practice guideline for the pharmacological management of acute dental pain associated with tooth extractions and toothache applicable to ED settings, hospitals, and urgent care clinics where definitive dental treatment is not immediately available.

Methods: A guideline panel convened by the American Dental Association, the ADA Science & Research Institute, the University of Pittsburgh School of Dental Medicine, and Penn Dental Medicine examined the effect of opioid and non-opioid analgesics; local anesthetics, including blocks; corticosteroids; and topical anesthetics on acute dental pain.

View Article and Find Full Text PDF
Article Synopsis
  • - COVID-19 convalescent plasma (CCP) may be beneficial for immunocompromised patients, but the FDA's current threshold for qualifying plasma based on antibody levels might be too low.
  • - A study evaluated antibody levels in blood donors with different infection and vaccination histories, revealing that those with hybrid immunity (infection followed by vaccination) had higher antibody levels and better neutralizing capabilities.
  • - The research suggests establishing new test-based criteria for qualifying CCP, highlighting that plasma with high antibody levels could effectively neutralize various COVID-19 variants for several months after infection or vaccination.
View Article and Find Full Text PDF

Objective: Existing research suggests that emotion plays an important role in airway inflammation and asthma symptom control. The objective of this study was to determine whether difficulties regulating emotion were associated with overuse of short-acting inhaled medications and acute medical care usage in adults with asthma.

Methods: The sample included 401 adults with asthma recruited from an online panel of adults with chronic respiratory disease.

View Article and Find Full Text PDF

Introduction: Insomnia is a prevalent sleep disorder that negatively impacts daytime functioning and quality of life. Breast cancer patients report higher rates of insomnia and more circadian disruption than other cancer groups. Approximately 50% of patients experience acute insomnia following breast cancer diagnosis, which often persists during cancer treatment and rehabilitation.

View Article and Find Full Text PDF

Purpose: There is a lack of systematic solutions to manage supportive care issues in racial/ethnic minorities (REM) receiving treatment for cancer. We developed and implemented an electronic patient-reported outcome (ePRO)-driven symptom management tool led by oncology pharmacists in a majority-minority cancer center located in Southern California. This study was designed to evaluate the implementation outcomes of our multilevel intervention.

View Article and Find Full Text PDF